Healthcare
Live Price
Offline$2.31
+7.44% today
1Y Change
-66.92%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Exicure, Inc. (XCUR) is a Healthcare stock with a market cap of $20.00M and listed on NASDAQ. The stock last traded around $2.31 and down 66.9% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +50.3%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +50.3%, free cash flow -194.0% with operating margin 0.0% and ROIC -36.1%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines XCUR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XCUR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XCUR Max Drawdown
-75.73%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XCUR and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
-$483.0K
-101.7% YoY
FY Net Income
-$64.1M
-2382.6% YoY
Free Cash Flow
-$35.8M
-0.3% YoY
Revenue Growth
-100.0%
EPS Growth
+50.3%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 500K | 0 | 29M | -483K |
| Gross Profit | -460K | 500K | -1M | 27M | -483K |
| Operating Income | -10M | -12M | -15M | -2M | -63M |
| EBITDA | -10M | -9M | -16M | 78K | -61M |
| Net Income | -5M | -10M | -17M | -3M | -64M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4M | 13M | 816K | 9M | 35M |
| Total Assets | 14M | 15M | 12M | 23M | 65M |
| Total Liabilities | 10M | 8M | 9M | 8M | 54M |
| Shareholder Equity | 4M | 7M | 3M | 15M | 11M |
| Total Debt | 176K | 6M | 7M | 7M | 15M |
| Net Debt | -4M | -7M | 6M | -1M | -20M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
35M
+2.4% YoY
Capital Expenditures
968K
-9580.0% YoY
Free Cash Flow
36M
-0.3% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-63.6%
Debt / Equity
0.04x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.